SFXN2 | Sideroflexin 2 | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC15A4 | Solute carrier family 15 (oligopeptide transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A20 | Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A9 | Solute carrier family 2 (facilitated glucose transporter), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35B3 | Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35D2 | Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A7 | Solute carrier family 38, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC39A14 | Solute carrier family 39 (zinc transporter), member 14 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SLC39A6 | Solute carrier family 39 (zinc transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A3 | Solute carrier family 41, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC8A2 | Solute carrier family 8 (sodium/calcium exchanger), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SYVN1 | Synovial apoptosis inhibitor 1, synoviolin | Predicted membrane proteins
| | | | | Expressed in all |
TECR | Trans-2,3-enoyl-CoA reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
TMEM164 | Transmembrane protein 164 | Predicted membrane proteins
| | | | | Expressed in all |
TMEM201 | Transmembrane protein 201 | Predicted membrane proteins
| | | | | Mixed |
TMEM259 | Transmembrane protein 259 | Predicted membrane proteins
| | | | | Expressed in all |
TMEM45A | Transmembrane protein 45A | Predicted membrane proteins
| | | | | Tissue enriched |
TMEM67 | Transmembrane protein 67 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
TMEM87A | Transmembrane protein 87A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TSPAN7 | Tetraspanin 7 | CD markers Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TSPO | Translocator protein (18kDa) | Cancer-related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TTYH1 | Tweety family member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
VMP1 | Vacuole membrane protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
YIF1A | Yip1 interacting factor homolog A (S. cerevisiae) | Predicted membrane proteins
| | | | | Expressed in all |
YIPF3 | Yip1 domain family, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
YIPF4 | Yip1 domain family, member 4 | Predicted membrane proteins
| | | | | Expressed in all |